Percutaneous Mechanical Circulatory Support Devices Market Analysis Covering Growth Drivers And Future Outlook
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Percutaneous Mechanical Circulatory Support Devices Market Between 2026 And 2030?
The percutaneous mechanical circulatory support devices market has experienced robust growth in its size over recent years. It is projected to expand from $2.46 billion in 2025 to $2.7 billion in 2026, showing a compound annual growth rate (CAGR) of 9.7%. The market’s past growth is attributable to an escalating burden of cardiovascular disease, a rise in cardiogenic shock cases, the adoption of minimally invasive procedures, the expansion of ICU care, and an aging population.
The percutaneous mechanical circulatory support devices market size is anticipated to experience robust expansion in the coming years. It is forecast to reach $3.87 billion by 2030, progressing at a compound annual growth rate (CAGR) of 9.4%. The growth during this forecast period can be attributed to elements such as AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the broadening scope of cath lab procedures, the demand for temporary heart support, and advanced pump technologies. Key trends identified for the forecast period include minimally invasive cardiac support, short-term hemodynamic assistance, high-risk PCI support devices, rapid deployment cardiac systems, and enhanced patient safety designs.
Access Your Free Sample Report For In-Depth Market Analysis:
What Major Factors Are Driving The Percutaneous Mechanical Circulatory Support Devices Market Forward?
The rising occurrence of cardiovascular diseases is projected to drive expansion within the percutaneous mechanical circulatory support devices market in the future. Cardiovascular diseases, abbreviated as CVDs, encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, myocardial infarctions, heart failure, cerebrovascular accidents, and hypertension. This growing prevalence of cardiovascular diseases stems from factors like an aging demographic, poor lifestyle decisions, excessive weight, high blood pressure, and inherited predispositions. Percutaneous mechanical circulatory support devices find application in cardiovascular diseases to enhance heart function, alleviate stress on the heart, and aid recovery during severe cardiac states. A notable example is provided by the Centers for Disease Control and Prevention, a US-based public health institute, which reported in October 2024 that in 2023, approximately 1 out of every 6 deaths due to cardiovascular diseases occurred in adults younger than 65 years old. Furthermore, a grand total of 919,032 people succumbed to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the escalating incidence of cardiovascular diseases is propelling the expansion of the percutaneous mechanical circulatory support (MCS) devices market.
Which Segment Types Are Examined In The Percutaneous Mechanical Circulatory Support Devices Market Segment Study?
The percutaneous mechanical circulatory support devices market covered in this report is segmented –
1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices
Which Trends Are Impacting The Progress Of The Percutaneous Mechanical Circulatory Support Devices Market?
Leading companies operating within the percutaneous mechanical circulatory support devices market are prioritizing the development of technologically advanced solutions, such as intra-aortic axial-flow devices, to improve patient outcomes and minimize surgical risks. An intra-aortic axial-flow device is a form of percutaneous mechanical circulatory support (MCS) device engineered to aid heart function by boosting blood flow from the left ventricle to the aorta. For example, in February 2023, Procyrion, Inc., a US-based medical device firm, announced the successful first-in-human application of its Aortix pump. This innovative device is designed to prevent acute kidney injury (AKI) in individuals undergoing cardiac surgery. Introduced via a catheter in the descending thoracic aorta, the Aortix pump enhances renal perfusion while simultaneously reducing the heart’s workload during surgery. It accomplishes this by improving both renal and systemic perfusion while concurrently lessening the strain on the heart, rendering it particularly beneficial for patients with compromised left ventricular function and renal impairment. With the capacity to deliver up to 5.0 liters of flow per minute, the Aortix pump is intended for temporary deployment during procedures like percutaneous coronary interventions (PCI).
Which Players Are Part Of The Competitive Landscape Of The Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.
Get The Full Percutaneous Mechanical Circulatory Support Devices Market Report:
Where Is The Percutaneous Mechanical Circulatory Support Devices Market Primarily Concentrated By Region?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Percutaneous Mechanical Circulatory Support Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2026, By The Business Research Company
Peripheral Vascular Devices And Equipment Market Report 2026
Cardiovascular Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Cardiac Assist Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
